Open-Label Pilot Study of Long-Acting Injectable Naltrexone Treatment for Cannabis Dependence
Phase of Trial: Phase I/II
Latest Information Update: 21 Sep 2017
Price : $35 *
At a glance
- Drugs Naltrexone (Primary)
- Indications Drug dependence
- Focus Adverse reactions; Therapeutic Use
- 17 May 2016 Status changed from recruiting to completed.
- 31 Aug 2015 Planned End Date changed from 1 Sep 2015 to 1 Feb 2016 as reported by ClinicalTrials.gov record.
- 31 Aug 2015 Planned primary completion date changed from 1 Sep 2015 to 1 Feb 2016 as reported by ClinicalTrials.gov record.